Zenith Capital Corp, is a Canada-based biotechnology investment company. The Company’s wholly owned subsidiary is Zenith Epigenetics Ltd. Zenith Epigenetics is a clinical stage biotechnology company is focused on the discovery and development of therapeutics for the treatment of cancer and other disorders with unmet medical need. The Company is focused on developing various combinations of Bromodomain and ExtraTerminal domain (BET) inhibitors with other targeted agents. Its...